Avalo Therapeutics, Inc. (AVTX)
19.26
-0.57
(-2.87%)
USD |
NASDAQ |
Aug 24, 16:00
19.26
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Market Cap : 1.019B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.049B |
| August 20, 2026 | 1.048B |
| August 19, 2026 | 1.098B |
| August 18, 2026 | 1.043B |
| August 17, 2026 | 1.055B |
| August 14, 2026 | 1.036B |
| August 13, 2026 | 1.029B |
| August 12, 2026 | 1.034B |
| August 11, 2026 | 1.030B |
| August 10, 2026 | 1.046B |
| August 07, 2026 | 969.14M |
| August 06, 2026 | 989.24M |
| August 05, 2026 | 996.65M |
| August 04, 2026 | 980.25M |
| August 03, 2026 | 444.71M |
| July 31, 2026 | 449.64M |
| July 30, 2026 | 477.73M |
| July 29, 2026 | 468.36M |
| July 28, 2026 | 480.93M |
| July 27, 2026 | 480.44M |
| July 24, 2026 | 454.32M |
| July 23, 2026 | 437.57M |
| July 22, 2026 | 447.18M |
| July 21, 2026 | 463.68M |
| July 20, 2026 | 448.65M |
| Date | Value |
|---|---|
| July 17, 2026 | 477.23M |
| July 16, 2026 | 440.52M |
| July 15, 2026 | 457.03M |
| July 14, 2026 | 453.83M |
| July 13, 2026 | 465.90M |
| July 10, 2026 | 473.29M |
| July 09, 2026 | 491.52M |
| July 08, 2026 | 473.29M |
| July 07, 2026 | 474.28M |
| July 06, 2026 | 491.77M |
| July 02, 2026 | 464.18M |
| July 01, 2026 | 425.99M |
| June 30, 2026 | 455.31M |
| June 29, 2026 | 475.26M |
| June 26, 2026 | 448.41M |
| June 25, 2026 | 443.48M |
| June 24, 2026 | 447.42M |
| June 23, 2026 | 439.29M |
| June 22, 2026 | 420.81M |
| June 18, 2026 | 362.18M |
| June 17, 2026 | 379.42M |
| June 16, 2026 | 353.06M |
| June 15, 2026 | 359.71M |
| June 12, 2026 | 363.65M |
| June 11, 2026 | 336.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.100B |
| Incyte Corp. | 25.72B |
| AbbVie, Inc. | 467.37B |
| Rezolute, Inc. | 481.46M |
| Alnylam Pharmaceuticals, Inc. | 31.57B |
Market Cap Related Metrics
| PS Ratio | 7852.71 |
| Price to Book Value | 2.271 |
| Price | 19.26 |
| Earnings Yield | -24.60% |